| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2025―Dez―05 |
PapMV nanoparticles: A novel pathway to SARS-CoV-2 protection, distinct from Imidazoquinolines |
Marilène Bolduc, Philippe Saint-Louis, Damien Carignan, Caroline Garneau, Yann Breton, Martin Pelletier, et al. (+9) Anne Rancourt, Masahiko S. Satoh, Sachiko Sato, Mégan Gilbert, Henintsoa Rabezanahary, Mariana Baz, Isabelle Dubuc, Louis Flamand, Denis Leclerc |
| 2 |
[GO] |
2023―Apr―11 |
Neutralization of the new coronavirus by extracting their spikes using engineered liposomes |
Zhenjiang Zhang, Michael R. King |
| 3 |
[GO] |
2023―Jan―14 |
Treatment of infection and inflammation associated with COVID-19, multi-drug resistant pneumonia and fungal sinusitis by nebulizing a nanosilver solution |
Patricia L. Nadworny, William L. Hickerson, Holly Denise Holley-Harrison, David C. Bloom, Tristan R. Grams, Terri G. Edwards, et al. (+2) Gregory S. Schultz, Robert E. Burrell |
| 4 |
[GO] |
2022―Nov―01 |
Simultaneously ultrasensitive and quantitative detection of influenza A virus, SARS-CoV-2, and respiratory syncytial virus via multichannel magnetic SERS-based lateral flow immunoassay |
Zhenzhen Liu, Chongwen Wang, Shuai Zheng, Xingsheng Yang, Han Han, Yuwei Dai, Rui Xiao |
| 5 |
[GO] |
2022―Sep―13 |
Modular nanoarray vaccine for SARS-CoV-2 |
Karen Zagorski, Kabita Pandey, Rajesh Rajaiah, Omalla A. Olwenyi, Aditya N. Bade, Arpan Acharya, et al. (+4) Morgan Johnston, Shaun Filliaux, Yuri L. Lyubchenko, Siddappa N. Byrareddy |
| 6 |
[GO] |
2022―Aug―28 |
Nano-multilamellar lipid vesicles promote the induction of SARS-CoV-2 immune responses by a protein-based vaccine formulation |
Monica Josiane Rodrigues-Jesus, Marianna Teixeira de Pinho Favaro, Aléxia Adrianne Venceslau-Carvalho, Maria Fernanda de Castro-Amarante, Bianca da Silva Almeida, Mariângela de Oliveira Silva, et al. (+6) Robert Andreata-Santos, Cecilia Gomes Barbosa, Samantha Carvalho Maia Brito, Lucio H. Freitas-Junior, Silvia Beatriz Boscardin, Luís Carlos de Souza Ferreira |
| 7 |
[GO] |
2022―Jul―26 |
Proof-of-concept for speedy development of rapid and simple at-home method for potential diagnosis of early COVID-19 mutant infection using nanogold and aptamer |
Satheesh Ellipilli, Hongzhi Wang, Wen-Jui Lee, Dan Shu, Peixuan Guo |
| 8 |
[GO] |
2022―Jul―16 |
A nanoparticle-based COVID-19 vaccine candidate elicits broad neutralizing antibodies and protects against SARS-CoV-2 infection |
Santa-Mariela Olivera-Ugarte, Marilène Bolduc, Marie-Ève Laliberté-Gagné, Léa-Jeanne Blanchette, Caroline Garneau, Maude Fillion, et al. (+12) Pierre Savard, Isabelle Dubuc, Louis Flamand, Omar Farnòs, Xingge Xu, Amine Kamen, Mégan Gilbert, Henintsoa Rabezanahary, Martina Scarrone, Christian Couture, Mariana Baz, Denis Leclerc |
| 9 |
[GO] |
2022―Jan―30 |
Recombinant VLPs empower RBM peptides showing no immunogenicity in native SARS-COV-2 protein to elicit a robust neutralizing antibody response |
Qiong Long, Ying Yang, Mengli Yang, Hongmei Bai, Wengjia Sun, Xu Yang, et al. (+3) Weiwei Huang, Duo Li, Yanbing Ma |
| 10 |
[GO] |
2021―Mrz―02 |
Synthesis and immunogenicity assessment of a gold nanoparticle conjugate for the delivery of a peptide from SARS-CoV-2 |
Susan Farfán-Castro, Mariano J. García Soto, Mauricio Comas-García, Jaime I. Arévalo-Villalobos, Gabriela Palestino, Omar González-Ortega, Sergio Rosales-Mendoza |
|
